CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults
Sign Up to like & getrecommendations! Published in 2017 at "Neurobiology of Aging"
DOI: 10.1016/j.neurobiolaging.2016.09.012
Abstract: Cerebrospinal fluid (CSF) neurofilament light (NFL) is a marker of axonal degeneration. We tested whether CSF NFL levels predict hippocampal atrophy rate in cognitively healthy older adults independently of the established CSF Alzheimer's disease (AD)… read more here.
Keywords: neurofilament light; hippocampal atrophy; csf neurofilament; levels predict ... See more keywords
Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis
Sign Up to like & getrecommendations! Published in 2017 at "Inflammatory Bowel Diseases"
DOI: 10.1097/mib.0000000000001157
Abstract: Background: Mucosal healing as measured by endoscopic activity is the therapeutic target for ulcerative colitis (UC) and associated with improved outcomes. We investigated the clinical utility of fecal calprotectin (FC) levels to predict depth of… read more here.
Keywords: remission; levels predict; ulcerative colitis; calprotectin levels ... See more keywords
Elevated D‐dimer levels predict adverse outcomes in hospitalised elderly patients with chronic heart failure
Sign Up to like & getrecommendations! Published in 2019 at "Internal Medicine Journal"
DOI: 10.1111/imj.14322
Abstract: Elevated D‐dimer levels have been associated with poor outcomes in patients with cardiovascular disease. read more here.
Keywords: adverse outcomes; levels predict; predict adverse; elevated dimer ... See more keywords
Circulating selenoprotein P levels predict glucose‐lowering and insulinotropic effects of metformin, but not alogliptin: A post‐hoc analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Diabetes Investigation"
DOI: 10.1111/jdi.13949
Abstract: Selenoprotein P (SeP; encoded by SEPP1 in humans) is a hepatokine that causes impaired insulin secretion and insulin resistance. Metformin downregulates SELENOP promoter activity through an adenosine monophosphate‐activated kinase–forkhead box protein O3a pathway in hepatocytes. This study… read more here.
Keywords: circulating selenoprotein; predict glucose; selenoprotein; glucose lowering ... See more keywords
Circulating trimethylamine N‐oxide levels do not predict 10‐year survival in patients with or without coronary heart disease
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Internal Medicine"
DOI: 10.1111/joim.13550
Abstract: Trimethylamine N‐oxide (TMAO) is an amine oxide generated by gut microbial metabolism. TMAO may contribute to atherothrombosis and systemic inflammation. However, the prognostic value of circulating TMAO for risk stratification is uncertain. read more here.
Keywords: predict year; circulating trimethylamine; trimethylamine oxide; oxide levels ... See more keywords
Chromogranin A levels to predict survival in resectable pancreatic neuroendocrine tumors.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e15775
Abstract: e15775Background: To determine whether Chromogranin A (CGA) predicts outcome after Cytoreductive Surgery (CRS) for Pancreatic Neuroendocrine Tumors (PNETs). CGA is used by clinicians to monitor pro... read more here.
Keywords: predict survival; chromogranin levels; pancreatic neuroendocrine; levels predict ... See more keywords
Do Cortisol Levels Predict the Outcome of Pediatric Oncology Patients Admitted to the PICU for Concerns of Sepsis
Sign Up to like & getrecommendations! Published in 2019 at "Pediatrics"
DOI: 10.1542/peds.144.2_meetingabstract.375
Abstract: Introduction Sepsis is the leading cause of death in children worldwide and the diagnosis and treatment of sepsis in pediatric patients are often guided by studies of adult patients. Sepsis is a leading cause of… read more here.
Keywords: sepsis; levels predict; cortisol levels; pediatric oncology ... See more keywords
Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors
Sign Up to like & getrecommendations! Published in 2020 at "Immune Network"
DOI: 10.4110/in.2020.20.e27
Abstract: Although various studies on predictive markers in the use of PD-1/PD-L1 inhibitors are in progress, only PD-L1 expression levels in tumor tissues are currently used. In the present study, we investigated whether baseline serum levels… read more here.
Keywords: advanced non; baseline serum; response; response patients ... See more keywords